KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to 17.86%.

  • Globus Medical's EBIT Margin rose 101700.0% to 17.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.39%, marking a year-over-year increase of 87100.0%. This contributed to the annual value of 6.59% for FY2024, which is 19000.0% down from last year.
  • Globus Medical's EBIT Margin amounted to 17.86% in Q3 2025, which was up 101700.0% from 10.21% recorded in Q2 2025.
  • Globus Medical's EBIT Margin's 5-year high stood at 25.71% during Q2 2022, with a 5-year trough of 0.11% in Q3 2023.
  • Over the past 5 years, Globus Medical's median EBIT Margin value was 17.86% (recorded in 2025), while the average stood at 14.58%.
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 354400bps in 2021, then plummeted by -233900bps in 2023.
  • Quarter analysis of 5 years shows Globus Medical's EBIT Margin stood at 7.28% in 2021, then surged by 170bps to 19.68% in 2022, then crashed by -92bps to 1.64% in 2023, then soared by 458bps to 9.17% in 2024, then skyrocketed by 95bps to 17.86% in 2025.
  • Its EBIT Margin stands at 17.86% for Q3 2025, versus 10.21% for Q2 2025 and 16.22% for Q1 2025.